Literature DB >> 27333055

Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy.

Stéphanie Moortgat1, Julie Désir2, Valérie Benoit3, Sébastien Boulanger3, Hélène Pendeville4, Marie-Cécile Nassogne5, Damien Lederer3, Isabelle Maystadt3.   

Abstract

X-chromosome exome sequencing was performed to identify the genetic cause of syndromic intellectual disability in two unrelated families with suspected X-linked inheritance. In both families, affected males presented with severe intellectual disability, microcephaly, growth retardation, and epilepsy. A missense mutation (c.777T>G p.(Ile259Met)) and a frameshift mutation (c.1394_1397del p.(Ile465Serfs*4)) were identified in the EIF2S3 gene in the hemizygous state in affected patients, and in the heterozygous states female obligate carriers. A missense mutation in EIF2S3, coding for the gamma-subunit of the translation initiation factor eIF2, was reported once in a family presenting with similar clinical features. Morpholino-based knockdown of the zebrafish EIF2S3 ortholog (eif2s3) recapitulates the human microcephaly and short stature phenotype, supporting the pathogenicity of the identified variants. Our data confirm that EIF2S3 mutation is implicated in a rare, but recognizable, form of syndromic intellectual disability.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  X-exome sequencing; X-linked intellectual disability; epilepsy; microcephaly; morpholino; zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27333055     DOI: 10.1002/ajmg.a.37792

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMO.

Authors:  Martina Skopkova; Friederike Hennig; Byung-Sik Shin; Clesson E Turner; Daniela Stanikova; Katarina Brennerova; Juraj Stanik; Ute Fischer; Lyndal Henden; Ulrich Müller; Daniela Steinberger; Esther Leshinsky-Silver; Armand Bottani; Timea Kurdiova; Jozef Ukropec; Olga Nyitrayova; Miriam Kolnikova; Iwar Klimes; Guntram Borck; Melanie Bahlo; Stefan A Haas; Joo-Ran Kim; Leda E Lotspeich-Cole; Daniela Gasperikova; Thomas E Dever; Vera M Kalscheuer
Journal:  Hum Mutat       Date:  2017-01-23       Impact factor: 4.878

2.  Immunologic phenotype of a child with the MEHMO syndrome.

Authors:  I Trochanová; D Staníková; M Škopková; K Haštová; D Gašperíková; J Staník; P Čižnár
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

3.  Perspective: Modulating the integrated stress response to slow aging and ameliorate age-related pathology.

Authors:  Maxime J Derisbourg; Matías D Hartman; Martin S Denzel
Journal:  Nat Aging       Date:  2021-09-13

4.  Aspirin effects on platelet gene expression are associated with a paradoxical, increase in platelet function.

Authors:  Rachel A Myers; Thomas L Ortel; Alexander Waldrop; Sandeep Dave; Geoffrey S Ginsburg; Deepak Voora
Journal:  Br J Clin Pharmacol       Date:  2021-11-27       Impact factor: 4.335

5.  Expanding the phenotype of the recurrent truncating eIF2γ pathogenic variant p.(Ile465Serfs*4) identified in two brothers with MEHMO syndrome.

Authors:  Sofia Ygberg; Anna Lindstrand
Journal:  Clin Case Rep       Date:  2022-06-19

6.  Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia.

Authors:  Jielun Lu; Shuyi Chen; Huo Tan; Zhenqian Huang; Bo Li; Ling Liu; Yimin Chen; Xiaozhen Zeng; Yawei Zou; Lihua Xu
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-07       Impact factor: 4.553

Review 7.  The integrated stress response: From mechanism to disease.

Authors:  Mauro Costa-Mattioli; Peter Walter
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

8.  Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors

Authors:  Zafer Söylemez; Evrim Suna Arıkan; Mustafa Solak; Yüksel Arıkan; Çiğdem Tokyol; Hüseyin Şeker
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

9.  Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB.

Authors:  Sara K Young-Baird; Maíra Bertolessi Lourenço; Megan K Elder; Eric Klann; Stefan Liebau; Thomas E Dever
Journal:  Mol Cell       Date:  2019-12-10       Impact factor: 19.328

10.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.